These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 35711029)

  • 21. G Protein-Dependent Activation of the PKA-Erk1/2 Pathway by the Striatal Dopamine D1/D3 Receptor Heteromer Involves Beta-Arrestin and the Tyrosine Phosphatase Shp-2.
    Bono F; Tomasoni Z; Mutti V; Sbrini G; Kumar R; Longhena F; Fiorentini C; Missale C
    Biomolecules; 2023 Mar; 13(3):. PubMed ID: 36979407
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of dopamine D3 receptors in methamphetamine-induced behavioural sensitization and the characterization of dopamine receptors (D1R-D5R) gene expression in the brain.
    Su H; Wang X; Bai J; Fan Y; Du Y; Wei Z; Yan J; Yun K; Chen T
    Folia Neuropathol; 2022; 60(1):105-113. PubMed ID: 35359150
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contributions of dopamine D1, D2, and D3 receptor subtypes to the disruptive effects of cocaine on prepulse inhibition in mice.
    Doherty JM; Masten VL; Powell SB; Ralph RJ; Klamer D; Low MJ; Geyer MA
    Neuropsychopharmacology; 2008 Oct; 33(11):2648-56. PubMed ID: 18075489
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biased G Protein-Independent Signaling of Dopamine D
    Guitart X; Moreno E; Rea W; Sánchez-Soto M; Cai NS; Quiroz C; Kumar V; Bourque L; Cortés A; Canela EI; Bishop C; Newman AH; Casadó V; Ferré S
    Mol Neurobiol; 2019 Oct; 56(10):6756-6769. PubMed ID: 30919214
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of D2/D3 receptors increases efficacy of ropinirole in chronically 6-OHDA-lesioned Parkinsonian rats.
    Matsukawa N; Maki M; Yasuhara T; Hara K; Yu G; Xu L; Kim KM; Morgan JC; Sethi KD; Borlongan CV
    Brain Res; 2007 Jul; 1160():113-23. PubMed ID: 17573046
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reciprocal regulation of dopamine D1 and D3 receptor function and trafficking by heterodimerization.
    Fiorentini C; Busi C; Gorruso E; Gotti C; Spano P; Missale C
    Mol Pharmacol; 2008 Jul; 74(1):59-69. PubMed ID: 18424554
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Opposing aging-related shift of excitatory dopamine D1 and inhibitory D3 receptor protein expression in striatum and spinal cord.
    Keeler BE; Lallemand P; Patel MM; de Castro Brás LE; Clemens S
    J Neurophysiol; 2016 Jan; 115(1):363-9. PubMed ID: 26561599
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current drug treatments targeting dopamine D3 receptor.
    Leggio GM; Bucolo C; Platania CB; Salomone S; Drago F
    Pharmacol Ther; 2016 Sep; 165():164-77. PubMed ID: 27343365
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Severity of Dyskinesia and D3R Signaling Changes Induced by L-DOPA Treatment of Hemiparkinsonian Rats Are Features Inherent to the Treated Subjects.
    Albarrán-Bravo S; Ávalos-Fuentes JA; Cortés H; Rodriguez-Sánchez M; Leyva-García N; Rangel-Barajas C; Erlij D; Florán B
    Biomolecules; 2019 Sep; 9(9):. PubMed ID: 31480516
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chirality of Novel Bitopic Agonists Determines Unique Pharmacology at the Dopamine D3 Receptor.
    Adhikari P; Xie B; Semeano A; Bonifazi A; Battiti FO; Newman AH; Yano H; Shi L
    Biomolecules; 2021 Apr; 11(4):. PubMed ID: 33924613
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective overexpression of dopamine D3 receptors in the striatum disrupts motivation but not cognition.
    Simpson EH; Winiger V; Biezonski DK; Haq I; Kandel ER; Kellendonk C
    Biol Psychiatry; 2014 Nov; 76(10):823-31. PubMed ID: 24387821
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coexpression of dopamine D1 and D3 receptors in islands of Calleja and shell of nucleus accumbens of the rat: opposite and synergistic functional interactions.
    Ridray S; Griffon N; Mignon V; Souil E; Carboni S; Diaz J; Schwartz JC; Sokoloff P
    Eur J Neurosci; 1998 May; 10(5):1676-86. PubMed ID: 9751140
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New roles for dopamine D
    Farino ZJ; Morgenstern TJ; Maffei A; Quick M; De Solis AJ; Wiriyasermkul P; Freyberg RJ; Aslanoglou D; Sorisio D; Inbar BP; Free RB; Donthamsetti P; Mosharov EV; Kellendonk C; Schwartz GJ; Sibley DR; Schmauss C; Zeltser LM; Moore H; Harris PE; Javitch JA; Freyberg Z
    Mol Psychiatry; 2020 Sep; 25(9):2070-2085. PubMed ID: 30626912
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dimerization of dopamine D1 and D3 receptors in the regulation of striatal function.
    Fiorentini C; Busi C; Spano P; Missale C
    Curr Opin Pharmacol; 2010 Feb; 10(1):87-92. PubMed ID: 19837631
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activity, non-selective attention and emotionality in dopamine D2/D3 receptor knock-out mice.
    Vallone D; Pignatelli M; Grammatikopoulos G; Ruocco L; Bozzi Y; Westphal H; Borrelli E; Sadile AG
    Behav Brain Res; 2002 Mar; 130(1-2):141-8. PubMed ID: 11864730
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dopamine D3 and acetylcholine nicotinic receptor heteromerization in midbrain dopamine neurons: Relevance for neuroplasticity.
    Bontempi L; Savoia P; Bono F; Fiorentini C; Missale C
    Eur Neuropsychopharmacol; 2017 Apr; 27(4):313-324. PubMed ID: 28187919
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adenosine heteroreceptor complexes in the basal ganglia are implicated in Parkinson's disease and its treatment.
    Borroto-Escuela DO; Fuxe K
    J Neural Transm (Vienna); 2019 Apr; 126(4):455-471. PubMed ID: 30637481
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dopamine D3 receptor is decreased and D2 receptor is elevated in the striatum of Parkinson's disease.
    Ryoo HL; Pierrotti D; Joyce JN
    Mov Disord; 1998 Sep; 13(5):788-97. PubMed ID: 9756147
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroadaptations to hyperdopaminergia in dopamine D3 receptor-deficient mice.
    Le Foll B; Diaz J; Sokoloff P
    Life Sci; 2005 Jan; 76(11):1281-96. PubMed ID: 15642598
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dopamine D1 receptor agonism induces dynamin related protein-1 inhibition to improve mitochondrial biogenesis and dopaminergic neurogenesis in rat model of Parkinson's disease.
    Mishra A; Singh S; Tiwari V; Bano S; Shukla S
    Behav Brain Res; 2020 Jan; 378():112304. PubMed ID: 31626851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.